This is one of the most discussed stacks in the peptide world, and once you understand the mechanism it makes complete sense why. These two compounds work on the same system — your growth hormone axis — but from different angles, creating an effect that's greater than either alone.
Your Growth Hormone System, Briefly
Your pituitary gland releases growth hormone (GH) in pulses throughout the day, with the largest pulse typically occurring during deep sleep. GH drives fat metabolism, muscle protein synthesis, tissue repair, and cellular regeneration. As we age, these GH pulses become less frequent and less robust — starting as early as the mid-twenties.[1]
Two signals regulate this release from the hypothalamus: Growth Hormone-Releasing Hormone (GHRH), which triggers release, and somatostatin, which suppresses it. The balance between these determines how much GH you produce.
CJC-1295: The GHRH Analog
CJC-1295 is a synthetic peptide that mimics GHRH — specifically, it binds to GHRH receptors in the pituitary and stimulates GH release. The modified version (with DAC — Drug Affinity Complex) has a much longer half-life than natural GHRH, meaning fewer injections are needed to sustain the signal.[2]
Clinical studies in healthy adults demonstrated that CJC-1295 produced dose-dependent increases in GH and IGF-1 (insulin-like growth factor 1, which mediates many of GH's anabolic effects) with a favorable safety profile.[3]
Ipamorelin: The Clean GH Secretagogue
Ipamorelin works differently — it's a selective GH secretagogue that mimics the hormone ghrelin, binding to ghrelin receptors in the pituitary to stimulate GH release. What makes it particularly well-regarded is selectivity: unlike older GH secretagogues, it does not significantly raise cortisol, prolactin, or ACTH — hormones you generally don't want chronically elevated.[4]
Studies have shown Ipamorelin produces a strong, clean GH pulse with minimal interference with other hormonal systems — making it one of the better-tolerated peptides in this class.[5]
Why Stack Them?
GHRH (mimicked by CJC-1295) and ghrelin pathway agonists (mimicked by Ipamorelin) work on different receptors and synergize in the pituitary. Clinical and preclinical research shows that combining a GHRH analog with a GH secretagogue produces greater GH release than either alone — roughly additive to synergistic in effect.[6]
"The appeal of this stack is that it works with your body's existing feedback system rather than bypassing it. You're stimulating your pituitary to release your own GH in natural pulses — not injecting synthetic HGH directly."
Potential Benefits Studied
Research on GH optimization in adults with age-related GH decline has shown potential improvements in lean body mass, reduction in visceral fat, improved sleep quality (particularly deep sleep), and enhanced recovery from physical exertion.[7] For someone on a GLP-1 journey managing significant weight loss, the muscle preservation and metabolic implications of GH optimization are genuinely relevant conversations to have with your physician.
The Muscle Preservation Angle
One of the most significant concerns on any aggressive weight loss protocol — GLP-1 or otherwise — is losing lean muscle alongside fat. GH plays a key role in protein synthesis and muscle preservation. This is part of why the CJC-1295/Ipamorelin conversation has grown among people on GLP-1 medications looking to protect their body composition.[8]
Typical Protocol Notes
Physician-supervised protocols typically involve subcutaneous injection, often before bed to align with the body's natural GH pulse cycle. Because GH release is suppressed when insulin and blood sugar are elevated, these peptides are generally not taken with meals. Cycle structures vary; physicians often recommend periodic breaks to maintain pituitary sensitivity.
Side effects reported in studies include transient water retention, mild tingling or numbness, and occasional headaches — generally mild and dose-related.[3]